These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9083839)

  • 1. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay.
    Singh J
    J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839
    [No Abstract]   [Full Text] [Related]  

  • 2. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay.
    Dasgupta A; Saldana S; Kinnaman G; Smith M; Johansen K
    Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive results with Emit II amphetamine/methamphetamine assay in users of common psychotropic drugs.
    Smith-Kielland A; Olsen KM; Christophersen AS
    Clin Chem; 1995 Jun; 41(6 Pt 1):951-2. PubMed ID: 7768025
    [No Abstract]   [Full Text] [Related]  

  • 4. Unavailability of drug metabolite reference material to evaluate false-positive results for monoclonal EMIT-d.a.u. assay of amphetamine.
    Poklis A
    Clin Chem; 1992 Dec; 38(12):2560. PubMed ID: 1458603
    [No Abstract]   [Full Text] [Related]  

  • 5. High amphetamine/methamphetamine concentrations in urine can cause error codes on the Ortho Vitros® Fusion 5,1 FS automated chemistry analyzer.
    Johnson-Davis KL; Thompson CD; Clark CJ; McMillin GA; Lehman CM
    J Anal Toxicol; 2010 Nov; 34(9):607-8. PubMed ID: 21073817
    [No Abstract]   [Full Text] [Related]  

  • 6. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Papa P; Rocchi L; Mainardi C; Donzelli G
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine.
    D'Nicuola J; Jones R; Levine B; Smith ML
    J Anal Toxicol; 1992; 16(4):211-3. PubMed ID: 1501473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine interference with standard amphetamine immunoassay.
    Liu L; Wheeler SE; Rymer JA; Lower D; Zona J; Peck Palmer OM; Tamama K
    Clin Chim Acta; 2015 Jan; 438():307-8. PubMed ID: 25242739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing.
    Woodworth A; Saunders AN; Koenig JW; Moyer TP; Turk J; Dietzen DJ
    Clin Chem; 2006 Apr; 52(4):743-6. PubMed ID: 16455869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods.
    Przekop MA; Manno JE; Kunsman GW; Cockerham KR; Manno BR
    J Anal Toxicol; 1991; 15(6):323-6. PubMed ID: 1779660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays.
    Melanson SE; Lee-Lewandrowski E; Griggs DA; Long WH; Flood JG
    Arch Pathol Lab Med; 2006 Dec; 130(12):1834-8. PubMed ID: 17149959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine cross-reactivity in the EMIT d.a.u. Monoclonal Amphetamine/Methamphetamine Assay.
    Kelly KL
    Clin Chem; 1990 Jul; 36(7):1391-2. PubMed ID: 2372968
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine.
    Verstraete AG; Heyden FV
    J Anal Toxicol; 2005; 29(5):359-64. PubMed ID: 16105261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of EMIT amphetamine immunoassays to urinary desoxyephedrine following Vicks inhaler use.
    Poklis A; Moore KA
    Ther Drug Monit; 1995 Feb; 17(1):89-94. PubMed ID: 7725384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers.
    Poklis A; Jortani SA; Brown CS; Crooks CR
    J Anal Toxicol; 1993 Sep; 17(5):284-6. PubMed ID: 8107462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine/methamphetamine assay.
    Grinstead GF
    Clin Chem; 1989 Sep; 35(9):1998-9. PubMed ID: 2673588
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry.
    Thurman EM; Pedersen MJ; Stout RL; Martin T
    J Anal Toxicol; 1992; 16(1):19-27. PubMed ID: 1640694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Poklis A; Hall KV; Still J; Binder SR
    J Anal Toxicol; 1991; 15(2):101-3. PubMed ID: 2051743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External quality assessment of Syva Emit and Abbott TDx II assays for methotrexate in serum.
    Wilson JF; Tsanaclis LM; Barnett K
    Ther Drug Monit; 1996 Dec; 18(6):721-3. PubMed ID: 8946672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.